|
1
|
Wen PY and Kesari S: Malignant gliomas in
adults. N Engl J Med. 359:492–507. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Stupp R, Mason WP, van den Bent MJ, Weller
M, Fisher B, Taphoorn MJ, Belanger K, Brandes AA, Marosi C, Bogdahn
U, et al: Radiotherapy plus concomitant and adjuvant temozolomide
for glioblastoma. N Engl J Med. 352:987–996. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Baek D, Villén J, Shin C, Camargo FD, Gygi
SP and Bartel DP: The impact of microRNAs on protein output.
Nature. 455:64–71. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Bartel DP: MicroRNAs: Genomics,
biogenesis, mechanism and function. Cell. 116:281–297. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Miska EA: How microRNAs control cell
division, differentiation and death. Curr Opin Genet Dev.
15:563–568. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Cristiano BE, Chan JC, Hannan KM, Lundie
NA, Marmy-Conus NJ, Campbell IG, Phillips WA, Robbie M, Hannan RD
and Pearson RB: A specific role for AKT3 in the genesis of ovarian
cancer through modulation of G(2)-M phase transition. Cancer Res.
66:11718–11725. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Koyama-Nasu R, Nasu-Nishimura Y, Todo T,
Ino Y, Saito N, Aburatani H, Funato K, Echizen K, Sugano H, Haruta
R, et al: The critical role of cyclin D2 in cell cycle progression
and tumor-igenicity of glioblastoma stem cells. Oncogene.
32:3840–3845. 2013. View Article : Google Scholar
|
|
8
|
Takai H, Masuda K, Sato T, Sakaguchi Y,
Suzuki T, Suzuki T, Koyama-Nasu R, Nasu-Nishimura Y, Katou Y, Ogawa
H, et al: 5-Hydroxymethylcytosine plays a critical role in
glioblastoma-genesis by recruiting the CHTOP-methylosome complex.
Cell Rep. 9:48–60. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Li S, Chen T, Zhong Z, Wang Y, Li Y and
Zhao X: microRNA-155 silencing inhibits proliferation and migration
and induces apoptosis by upregulating BACH1 in renal cancer cells.
Mol Med Rep. 5:949–954. 2012.PubMed/NCBI
|
|
10
|
Chang CC, Lin BR, Wu TS, Jeng YM and Kuo
ML: Input of microenvironmental regulation on colorectal cancer:
Role of the CCN family. World J Gastroenterol. 20:6826–6831. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Formosa A, Markert EK, Lena AM, Italiano
D, Finazzi-Agro' E, Levine AJ, Bernardini S, Garabadgiu AV, Melino
G and Candi E: MicroRNAs, miR-154, miR-299-5p, miR-376a, miR-376c,
miR-377, miR-381, miR-487b, miR-485-3p, miR-495 and miR-654-3p,
mapped to the 14q32.31 locus, regulate proliferation, apoptosis,
migration and invasion in metastatic prostate cancer cells.
Oncogene. 30:5173–5182. 2014. View Article : Google Scholar
|
|
12
|
Lehmann U, Streichert T, Otto B, Albat C,
Hasemeier B, Christgen H, Schipper E, Hille U, Kreipe HH and Länger
F: Identification of differentially expressed microRNAs in human
male breast cancer. BMC Cancer. 10:1092010. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Jin J, Li C, You J and Zhang B: miR-610
suppresses lung cancer cell proliferation and invasion by targeting
GJA3. Zhonghua Zhong Liu Za Zhi. 36:405–411. 2014.In Chinese.
PubMed/NCBI
|
|
14
|
Wang J, Zhang J, Wu J, Luo D, Su K, Shi W,
Liu J, Tian Y and Wei L: MicroRNA-610 inhibits the migration and
invasion of gastric cancer cells by suppressing the expression of
vaso-dilator-stimulated phosphoprotein. Eur J Cancer. 48:1904–1913.
2012. View Article : Google Scholar
|
|
15
|
Beltran AL, Ordonez JL, Otero AP, Blanca
A, Sevillano V, Sanchez-Carbayo M, Kirkali Z, Cheng L, Montironi R,
Prieto R and De Alava E: Fluorescence in situ hybridization
analysis of CCND3 gene as marker of progression in bladder
carcinoma. J Biol Regul Homeost Agents. 27:559–567. 2013.PubMed/NCBI
|
|
16
|
Soung YH, Lee JW, Nam SW, Lee JY, Yoo NJ
and Lee SH: Mutational analysis of AKT1, AKT2 and AKT3 genes in
common human carcinomas. Oncology. 70:285–289. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Agarwal E, Brattain MG and Chowdhury S:
Cell survival and metastasis regulation by Akt signaling in
colorectal cancer. Cell Signal. 25:1711–1719. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Paul-Samojedny M, Suchanek R, Borkowska P,
Pudełko A, Owczarek A, Kowalczyk M, Machnik G, Fila-Daniłow A and
Kowalski J: Knockdown of AKT3 (PKBγ) and PI3KCA suppresses cell
viability and proliferation and induces the apoptosis of
glioblastoma multiforme T98G cells. Biomed Res Int.
2014:7681812014. View Article : Google Scholar
|
|
19
|
Parry PV and Engh JA: The role of
cyclin-d2 in the tumorgenesis of glioblastoma. Neurosurgery.
71:N22–N23. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Guo Y, Yan K, Fang J, Qu Q, Zhou M and
Chen F: Let-7b expression determines response to chemotherapy
through the regulation of cyclin D1 in glioblastoma. J Exp Clin
Cancer Res. 32:412013. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Terada Y, Inoshita S, Nakashima O,
Kuwahara M, Sasaki S and Marumo F: Cyclins and the cyclin-kinase
system-their potential roles in nephrology. Nephrol Dial
Transplant. 13:1913–1916. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Féliers D, Frank MA and Riley DJ:
Activation of cyclin D1-Cdk4 and Cdk4-directed phosphorylation of
RB protein in diabetic mesangial hypertrophy. Diabetes.
51:3290–3299. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Roy SK, Srivastava RK and Shankar S:
Inhibition of PI3K/AKT and MAPK/ERK pathways causes activation of
FOXO transcription factor, leading to cell cycle arrest and
apoptosis in pancreatic cancer. J Mol Signal. 5:102010. View Article : Google Scholar : PubMed/NCBI
|
